Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek A Wainwright

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)|August 9, 2014
Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imagingYu Cheng, Qing Dai, Ramin A Morshed, et al.
Cancer Research|August 18, 2016
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor CellsAlan L Chang, Jason Miska, Derek A Wainwright, et al.
Frontiers in Immunology|July 3, 2020
Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting StrategiesLijie Zhai, April Bell, Erik Ladomersky, et al.
Oncotarget|May 29, 2018
Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancerAri J Rosenberg, Derek A Wainwright, Alfred Rademaker, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 21, 2018
A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor ModelJulius W Kim, J Robert Kane, Wojciech K Panek, et al.
Brain, Behavior, & Immunity - Health|April 4, 2022
A systematic review of pharmacologic treatment efficacy for depression in older patients with cancerErik E Rabin, Miri Kim, Andreas Mozny, et al.
Journal for Immunotherapy of Cancer|August 30, 2024
NKG2C/<i>KLRC2</i> tumor cell expression enhances immunotherapeutic efficacy against glioblastomaOlaya de Dios, M Angeles Ramírez-González, Irene Gómez-Soria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2018
IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced GlioblastomaErik Ladomersky, Lijie Zhai, Alicia Lenzen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2021
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in GlioblastomaLijie Zhai, April Bell, Erik Ladomersky, et al.
Journal for Immunotherapy of Cancer|July 28, 2022
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitryTeresa T Nguyen, Dong Ho Shin, Sagar Sohoni, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Small (Weinheim an Der Bergstrasse, Germany)|August 9, 2014
Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imagingYu Cheng, Qing Dai, Ramin A Morshed, et al.
Cancer Research|August 18, 2016
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor CellsAlan L Chang, Jason Miska, Derek A Wainwright, et al.
Frontiers in Immunology|July 3, 2020
Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting StrategiesLijie Zhai, April Bell, Erik Ladomersky, et al.
Oncotarget|May 29, 2018
Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancerAri J Rosenberg, Derek A Wainwright, Alfred Rademaker, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 21, 2018
A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor ModelJulius W Kim, J Robert Kane, Wojciech K Panek, et al.
Brain, Behavior, & Immunity - Health|April 4, 2022
A systematic review of pharmacologic treatment efficacy for depression in older patients with cancerErik E Rabin, Miri Kim, Andreas Mozny, et al.
Journal for Immunotherapy of Cancer|August 30, 2024
NKG2C/<i>KLRC2</i> tumor cell expression enhances immunotherapeutic efficacy against glioblastomaOlaya de Dios, M Angeles Ramírez-González, Irene Gómez-Soria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2018
IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced GlioblastomaErik Ladomersky, Lijie Zhai, Alicia Lenzen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2021
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in GlioblastomaLijie Zhai, April Bell, Erik Ladomersky, et al.
Journal for Immunotherapy of Cancer|July 28, 2022
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitryTeresa T Nguyen, Dong Ho Shin, Sagar Sohoni, et al.
Pageof 9